A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in AKT1 E17K Mutated Tumours
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in AKT1 E17K Mutated Tumours
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 4, Pages 1273
Publisher
MDPI AG
Online
2020-02-19
DOI
10.3390/ijms21041273
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Turning “Cold” Into “Hot” Tumors—Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers
- (2019) Lisa Sevenich Frontiers in Oncology
- Systemic and local immunosuppression in patients with high-grade meningiomas
- (2019) Yuping D. Li et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment
- (2019) Kayla V. Myers et al. Molecular Cancer
- AKT1E17K activates focal adhesion kinase and promotes melanoma brain metastasis
- (2019) David A Kircher et al. MOLECULAR CANCER RESEARCH
- Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma
- (2019) Shasha Liu et al. OncoImmunology
- Transcriptome signatures associated with meningioma progression
- (2019) Angela N. Viaene et al. Acta Neuropathologica Communications
- Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas
- (2019) Carmen Rapp et al. CLINICAL CANCER RESEARCH
- Prognostic Significance of Tumor-Associated Macrophage Content in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
- (2019) Ayan Tyagi Kumar et al. Frontiers in Oncology
- New insights into the genomic landscape of meningiomas identified FGFR3 in a subset of patients with favorable prognoses
- (2019) Aysha AlSahlawi et al. Oncotarget
- Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas
- (2019) Mark W. Youngblood et al. JOURNAL OF NEUROSURGERY
- Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors
- (2019) Akash J. Patel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transit amplifying cells coordinate mouse incisor mesenchymal stem cell activation
- (2019) Jemma Victoria Walker et al. Nature Communications
- Circulating Tumor Biomarkers in Meningiomas Reveal a Signature of Equilibrium Between Tumor Growth and Immune Modulation
- (2019) Erdogan Pekcan Erkan et al. Frontiers in Oncology
- Role of Macrophages in Brain Tumor Growth and Progression
- (2018) Elia Guadagno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Macrophage plasticity, polarization, and function in health and disease
- (2018) Abbas Shapouri-Moghaddam et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningioma
- (2018) Laura Pinton et al. OncoImmunology
- Diverse Functions of Macrophages in Different Tumor Microenvironments
- (2018) Ming Yang et al. CANCER RESEARCH
- PD-L1 expression in meningiomas
- (2018) Mahlon D. Johnson JOURNAL OF CLINICAL NEUROSCIENCE
- OUP accepted manuscript
- (2018) NEURO-ONCOLOGY
- Towards Molecular Classification of Meningioma: Evolving Treatment and Diagnostic Paradigms
- (2018) Dustin T. Proctor et al. World Neurosurgery
- Identification of PD-L2, B7-H3 and CTLA-4 immune checkpoint proteins in genetic subtypes of meningioma
- (2018) Dustin Proctor et al. OncoImmunology
- Molecular and translational advances in meningiomas
- (2018) Suganth Suppiah et al. NEURO-ONCOLOGY
- COSMIC: the Catalogue Of Somatic Mutations In Cancer
- (2018) John G Tate et al. NUCLEIC ACIDS RESEARCH
- Association Between CD133, CD44, and Nestin Expression and Prognostic Factors in High-Grade Meningioma
- (2018) Dai Kamamoto et al. World Neurosurgery
- Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism
- (2018) Jemma Dunn et al. EBioMedicine
- Mutant IDH1 regulates the tumor-associated immune system in gliomas
- (2017) Nduka M. Amankulor et al. GENES & DEVELOPMENT
- Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization
- (2017) Eleni Vergadi et al. JOURNAL OF IMMUNOLOGY
- DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis
- (2017) Felix Sahm et al. LANCET ONCOLOGY
- Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence
- (2017) Ümmügülsüm Yesilöz et al. NEURO-ONCOLOGY
- BAP1 mutations in high-grade meningioma: implications for patient care
- (2017) Ganesh M Shankar et al. NEURO-ONCOLOGY
- Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target
- (2017) Kayleigh Bassiri et al. EBioMedicine
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Tumor infiltrating immune cells in gliomas and meningiomas
- (2016) Patrícia Domingues et al. BRAIN BEHAVIOR AND IMMUNITY
- Genetic landscape of meningioma
- (2016) Sayaka Yuzawa et al. Brain Tumor Pathology
- Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas
- (2016) Victoria E Clark et al. NATURE GENETICS
- Oncogenic PI3K mutations are as common asAKT1andSMOmutations in meningioma
- (2016) Malak Abedalthagafi et al. NEURO-ONCOLOGY
- IL-10 secreted by M2 macrophage promoted tumorigenesis through interaction with JAK2 in glioma
- (2016) Ling Qi et al. Oncotarget
- Activation of multiple growth factor signalling pathways is frequent in meningiomas
- (2015) David A Hilton et al. NEUROPATHOLOGY
- Germline and somatic mutations in meningiomas
- (2015) Miriam J. Smith Cancer Genetics
- Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma
- (2015) Ziming Du et al. Oncotarget
- Identification of a 6-Cytokine Prognostic Signature in Patients with Primary Glioblastoma Harboring M2 Microglia/Macrophage Phenotype Relevance
- (2015) Jinquan Cai et al. PLoS One
- Effects of BRAF Mutations and BRAF Inhibition on Immune Responses to Melanoma
- (2014) K. M. Ilieva et al. MOLECULAR CANCER THERAPEUTICS
- Chromatin remodeling: from transcription to cancer
- (2014) Moshe Yaniv Cancer Genetics
- Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
- (2013) Priscilla K Brastianos et al. NATURE GENETICS
- Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma
- (2013) H. Kanno et al. NEURO-ONCOLOGY
- Association between Inflammatory Infiltrates and Isolated Monosomy 22/del(22q) in Meningiomas
- (2013) Patrícia Henriques Domingues et al. PLoS One
- Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO
- (2013) V. E. Clark et al. SCIENCE
- Immunophenotypic Identification and Characterization of Tumor Cells and Infiltrating Cell Populations in Meningiomas
- (2012) Patrícia H. Domingues et al. AMERICAN JOURNAL OF PATHOLOGY
- Meningioma
- (2008) Christine Marosi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth
- (2007) Marianne F. James et al. NEUROBIOLOGY OF DISEASE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now